Cutaneous and systemic plasmacytosis vs. cutaneous plasmacytic castleman disease: review and speculations about pathogenesis.

[1]  N. Chiorazzi,et al.  Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. , 2011, Blood.

[2]  S. Swerdlow,et al.  Cutaneous Marginal Zone Lymphomas Have Distinctive Features and Include 2 Subsets , 2010, The American journal of surgical pathology.

[3]  S. Lonial,et al.  Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease. , 2010, Journal of Clinical Oncology.

[4]  K. Schulte,et al.  Castleman's disease—a two compartment model of HHV8 infection , 2010, Nature Reviews Clinical Oncology.

[5]  B. Barlogie,et al.  Castleman disease in the 21st century: an update on diagnosis, assessment, and therapy. , 2010, Clinical advances in hematology & oncology : H&O.

[6]  L. Thomas,et al.  Primary cutaneous marginal zone lymphoma. , 2010, Critical reviews in oncology/hematology.

[7]  J. Frater,et al.  Cutaneous and systemic plasmacytosis in an Asian male born in the North American continent: A controversial entity potentially related to multicentric Castleman disease , 2010, Journal of cutaneous pathology.

[8]  N. Nishimoto,et al.  Interleukin‐6 as a Therapeutic Target in Candidate Inflammatory Diseases , 2010, Clinical pharmacology and therapeutics.

[9]  Andreas Radbruch,et al.  Organization of immunological memory by bone marrow stroma , 2010, Nature Reviews Immunology.

[10]  S. Yuen,et al.  IgG4-related Sclerosing Disease: A Potential New Etiology of Cutaneous Pseudolymphoma , 2009, The American journal of surgical pathology.

[11]  A. Yoshizawa,et al.  High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis--is this a cutaneous manifestation of IgG4-related disease? , 2009, Human pathology.

[12]  S. Chanock,et al.  Common genetic variants in candidate genes and risk of familial lymphoid malignancies , 2009, British journal of haematology.

[13]  R. Warnke,et al.  Castleman Disease: An Update on Classification and the Spectrum of Associated Lesions , 2009, Advances in anatomic pathology.

[14]  R. Bhatnagar,et al.  Isolated benign primary cutaneous plasmacytosis in children: two illustrative cases. , 2009, Archives of dermatology.

[15]  R. Bataille,et al.  Toll-like receptors: lessons to learn from normal and malignant human B cells. , 2008, Blood.

[16]  Ru-Song Meng,et al.  Cutaneous and systemic plasmacytosis: A Chinese case , 2008, The Journal of dermatology.

[17]  S. Devesa,et al.  Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996–2004 , 2008, Cancer Causes & Control.

[18]  M. Kojima,et al.  Clinical Implications of Idiopathic Multicentric Castleman Disease Among Japanese: A Report of 28 Cases , 2008, International journal of surgical pathology.

[19]  E. Hazneci,et al.  Intertriginous plasmacytosis with plasmoacanthoma: report of a typical case and review of the literature , 2008, International journal of dermatology.

[20]  Philip R. Cohen,et al.  Cutaneous castleman's disease responds to anti–interleukin-6 treatment , 2007, Molecular Cancer Therapeutics.

[21]  T. Kanekura,et al.  Multicentric Castleman Disease with Cutaneous Manifestations: Report of 2 Cases and Comparison with Systemic Plasmacytosis , 2007, Dermatology.

[22]  H. Tagami,et al.  Indurated nodules and plaques showing a dense plasma cell infiltrate as a cutaneous manifestation of Castleman's disease , 2007, The British journal of dermatology.

[23]  J. Diebold,et al.  Are multicentric Castleman's disease with cutaneous plasmacytosis and systemic plasmacytosis the same entity? , 2006, Histopathology.

[24]  M. Landthaler,et al.  Targeting T Cells to Hit B Cells: Successful Treatment of Cutaneous Plasmacytosis with Topical Pimecrolimus , 2006, Dermatology.

[25]  G. Remondino,et al.  False positive reactions in confirmatory tests for syphilis in presence of antiphospholipid antibodies: misdiagnosis with prognostic and social consequences. , 2006, Dermatology online journal.

[26]  E. Jordá,et al.  Cutaneous plasmacytosis associated with lung and anal carcinomas , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[27]  A. Jayaraman,et al.  Cutaneous Plasmacytosis: A Report of Five Cases with Immunohistochemical Evaluation for HHV-8 Expression , 2006, The American Journal of dermatopathology.

[28]  S. Kamel‐Reid,et al.  Immunoglobulin and T‐cell receptor gene rearrangement in Castleman's disease: molecular genetic analysis , 2006, Histopathology.

[29]  Kenneth C Anderson,et al.  Lenalidomide and thalidomide: mechanisms of action--similarities and differences. , 2005, Seminars in hematology.

[30]  C. Casper,et al.  The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care , 2005, British journal of haematology.

[31]  M. Kojima,et al.  Clinical Implication of Idiopathic Plasmacytic Lymphadenopathy with Polyclonal Hypergammaglobulinemia: A Report of 16 Cases , 2004, International journal of surgical pathology.

[32]  K. Yoshikawa,et al.  Treatment of facial lesion of cutaneous plasmacytosis with tacrolimus ointment. , 2003, Journal of the American Academy of Dermatology.

[33]  Virginia Pascual,et al.  Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. , 2003, Immunity.

[34]  H. Kutzner,et al.  Cutaneous involvement in multiple myeloma: a clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases. , 2003, Archives of dermatology.

[35]  P. Mclaughlin,et al.  Cutaneous and systemic plasmacytosis in a patient of Asian descent living in the United States. , 2002, The American Journal of dermatopathology.

[36]  H Ye,et al.  Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. , 2001, Blood.

[37]  B. Vion,et al.  Cutaneous Plasmacytosis: An Unusual Presentation Sharing Features with POEMS Syndrome? , 2001, Dermatology.

[38]  T. Kishimoto,et al.  Anti-interleukin 6 receptor antibody treatment in rheumatic disease , 2000, Annals of the rheumatic diseases.

[39]  M. Komine,et al.  Plasmacytosis: systemic or cutaneous, are they distinct? , 2000, Acta dermato-venereologica.

[40]  C. Boshoff,et al.  HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. , 2000, Blood.

[41]  R. Kano,et al.  Lack of evidence of human herpesvirus 8 DNA sequences in HIV‐negative patients with systemic plasmacytosis , 1999, The British journal of dermatology.

[42]  Watanabe,et al.  Failure to detect human herpesvirus type 8‐DNA sequences in systemic plasmacytosis from HIV‐uninfected Japanese patients , 1999, British Journal of Dermatology.

[43]  Hirao,et al.  Systemic plasmacytosis with deposition of interleukin (IL)‐6 and elevated expression of IL‐6 mRNA in the skin lesions , 1998, The British journal of dermatology.

[44]  M. Rico,et al.  Systemic plasmacytosis with cutaneous manifestations in a white man: successful therapy with cyclophosphamide/prednisone. , 1998, Journal of the American Academy of Dermatology.

[45]  K. Anderson,et al.  Interleukin‐6 in multiple myeloma and related plasma cell dyscrasias , 1998, Current opinion in hematology.

[46]  M. Corbellino,et al.  Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. , 1997, The American journal of pathology.

[47]  K. Nishioka,et al.  Increased plasma interleukin‐6 in cutaneous plasmacytoma: the effect of intralesional steroid therapy , 1997, The British journal of dermatology.

[48]  Yi Fang Liu,et al.  Kaposi's sarcoma‐associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus , 1997, Cancer.

[49]  Y. Nitta.  Case of malignant lymphoma associated with primary systemic plasmacytosis with polyclonal hypergammaglobulinemia. , 1997, The American Journal of dermatopathology.

[50]  M. Fujita,et al.  Successful treatment with topical PUVA of nodular cutaneous plasmacytosis associated with alopecia of the scalp , 1996, Clinical and experimental dermatology.

[51]  F. Sigaux,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.

[52]  J. Soulier,et al.  Molecular analysis of clonality in Castleman's disease. , 1995, Blood.

[53]  T. Matsui,et al.  Systemic and cutaneous plasmacytosis with multiple skin lesions and polyclonal hypergammaglobulinaemia: significant serum interleukin‐6 levels , 1992, The British journal of dermatology.

[54]  A. Nienhuis,et al.  Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. , 1990, The Journal of clinical investigation.

[55]  J. Miyazaki,et al.  IgG1 plasmacytosis in interleukin 6 transgenic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[56]  K. Lennert,et al.  Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant , 1989, Histopathology.

[57]  G. Frizzera.  Castleman's disease and related disorders. , 1988, Seminars in diagnostic pathology.

[58]  T. Miyagishima,et al.  [Systemic plasmacytosis. A case report]. , 1987, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[59]  A. Kukita,et al.  Systemic plasmacytosis. A syndrome of peculiar multiple skin eruptions, generalized lymphadenopathy, and polyclonal hypergammaglobulinemia. , 1986, Archives of dermatology.

[60]  M. Kanzaki,et al.  [Two cases of primary cutaneous plasma cytosis--the localized type of primary cutaneous plasmacytosis: a new clinical entity?]. , 1986, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology.

[61]  N. Ishii,et al.  A CASE OF CUTANEOUS PLASMACYTOSIS , 1984, The Journal of dermatology.

[62]  K. Kitamura,et al.  A CASE OF PLASMACYTOSIS WITH MULTIPLE PECULIAR ERUPTIONS , 1980, The Journal of dermatology.

[63]  U. Nydegger,et al.  [Cutaneous plasmacytosis and polyclonal cryo-immunoglobulinemia]. , 1978, Schweizerische medizinische Wochenschrift.

[64]  N. Harris,et al.  Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background. , 2010, American journal of clinical pathology.

[65]  T. Saida,et al.  Primary cutaneous plasmacytosis: report of three cases and review of the literature. , 1994, Dermatology.